Kim P. Kamdar, Director at OBALON THERAPEUTICS INC (OBLN), bought 13,400 shares at $15.00 ($201K) on 2016-10-12, disclosed to the SEC on 2016-10-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| EVFM | BUY | 2021-06-21 | $12K | — | Filing → |
| EVFM | BUY | 2020-06-16 | $15K | — | Filing → |
| OBLN | BUY | 2019-08-08 | $50K | — | Filing → |